Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kier

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Acta Medica Austriaca. Supplement|March 23, 2001
[High dosage therapy with stem cell transplantation in neuroendocrine carcinoma]V Buxhofer, R Ruckser, P Kier, et al.
Bone Marrow Transplantation|May 1, 1992
Detection of circulating endogenous interleukin-3 in extensive chronic graft-versus-host diseaseP Valent, K C Sillaber, R Scherrer, et al.
Bone Marrow Transplantation|September 1, 1994
Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humansM Hinterberger-Fischer, P Kier, J Spona, et al.
Acta Medica Austriaca. Supplement|March 23, 2001
[High dosage therapy and autologous peripheral stem cell transplantation in breast carcinoma]P Kier, R Ruckser, V Buxhofer, et al.
European Journal of Haematology|November 28, 2001
Successful treatment of invasive mould infection affecting lung and brain in an adult suffering from acute leukaemiaV Buxhofer, R Ruckser, P Kier, et al.
Bone Marrow Transplantation|August 1, 1990
Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodiesP Kier, E Penner, S Bakos, et al.
Acta Medica Austriaca. Supplement|January 1, 2003
[Significance of minimal residual disease for the estimation of the prognosis and for therapeutic decisions in solid tumors]W Hinterberger, Veronika Buxhofer, E Ogris, et al.
American Journal of Clinical Oncology|August 24, 2000
Elevation of plasma prolactin in patients undergoing autologous blood stem-cell transplantation for breast cancer: is its modulation a step toward posttransplant immunotherapy?M Hinterberger-Fischer, E Ogris, P Kier, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Acta Medica Austriaca. Supplement|March 23, 2001
[High dosage therapy with stem cell transplantation in neuroendocrine carcinoma]V Buxhofer, R Ruckser, P Kier, et al.
Bone Marrow Transplantation|May 1, 1992
Detection of circulating endogenous interleukin-3 in extensive chronic graft-versus-host diseaseP Valent, K C Sillaber, R Scherrer, et al.
Bone Marrow Transplantation|September 1, 1994
Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humansM Hinterberger-Fischer, P Kier, J Spona, et al.
Acta Medica Austriaca. Supplement|March 23, 2001
[High dosage therapy and autologous peripheral stem cell transplantation in breast carcinoma]P Kier, R Ruckser, V Buxhofer, et al.
European Journal of Haematology|November 28, 2001
Successful treatment of invasive mould infection affecting lung and brain in an adult suffering from acute leukaemiaV Buxhofer, R Ruckser, P Kier, et al.
Bone Marrow Transplantation|August 1, 1990
Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodiesP Kier, E Penner, S Bakos, et al.
Acta Medica Austriaca. Supplement|January 1, 2003
[Significance of minimal residual disease for the estimation of the prognosis and for therapeutic decisions in solid tumors]W Hinterberger, Veronika Buxhofer, E Ogris, et al.
American Journal of Clinical Oncology|August 24, 2000
Elevation of plasma prolactin in patients undergoing autologous blood stem-cell transplantation for breast cancer: is its modulation a step toward posttransplant immunotherapy?M Hinterberger-Fischer, E Ogris, P Kier, et al.
Pageof 3